As of November 6, nearly 1 million ETH (986,847) are queued for staking activation with a wait time of over 17 days, while only 4,320 ETH are waiting to exit staking. Despite a 13.4% price drop over the past 30 days to $2,229, stakers are not rushing to exit, indicating long-term holders remain committed. The staking queue limits supply but does not create new demand, making the 200-day moving average at $2,157 a key price support level. Investors should watch for a price close below this level, which could signal further declines, or a recovery above the 100-day moving average at $2,360 for potential price gains.
Ethereum staking queue and exit queue data provide context for readers as of Nov 07, 2026 01:32 WIB. For readers following the broader cryptocurrency market, here is Pluang's snapshot: out of 50 major cryptocurrencies priced on Pluang, 38 rose and 11 fell today. Notable movers include SXP (Solar) down 46.27% to Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% to Rp16,297 with a typical hold time of 85 days, and ZIL (Zilliqa) up 10.64% to Rp33 with a typical hold time of 134 days and Pluang order activity showing 29% sell and 71% buy.
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...
